| +0.24 / +1.21%|
The 4 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 40.00, with a high estimate of 52.00 and a low estimate of 38.00. The median estimate represents a +98.51% increase from the last price of 20.15.
The current consensus among 5 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.